ARTICLE | Politics, Policy & Law
FTC guidelines justify blocking biopharma M&A
Draft guidelines explain logic for blocking Amgen acquisition of Horizon, impact will be determined by courts
July 19, 2023 8:45 PM UTC
The FTC has released draft guidelines on the regulation of mergers that seek to explain and provide legal justification for the Biden administration’s attempts to broaden the scope of, and lower the threshold for, antitrust enforcement. The draft guidelines include justification for the FTC’s regulation of vertical mergers involving biopharma companies, including Amgen’s acquisition of Horizon.
Release of the guidelines starts the clock on a 60-day comment period. ...